A Study of Efavirenz in Combination With Stavudine and Didanosine
Clinical trial NCT00002225 · COMPLETED
Trial details
- NCT number
- NCT00002225
- Sponsor
- Dupont Merck
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.